摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-cyclohexyl-4-phenyI-4H-[1,2,4]triazole-3-thiol | 482615-79-2

中文名称
——
中文别名
——
英文名称
5-cyclohexyl-4-phenyI-4H-[1,2,4]triazole-3-thiol
英文别名
3-cyclohexyl-4-phenyl-1H-1,2,4-triazole-5-thione
5-cyclohexyl-4-phenyI-4H-[1,2,4]triazole-3-thiol化学式
CAS
482615-79-2
化学式
C14H17N3S
mdl
MFCD04036103
分子量
259.375
InChiKey
WYVKEKWKMYVFIC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.6
  • 重原子数:
    18
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.428
  • 拓扑面积:
    59.7
  • 氢给体数:
    1
  • 氢受体数:
    2

文献信息

  • Novel compound, polymerizable composition, color filter and production method thereof, solid-state imaging device, and planographic printing plate precursor
    申请人:FUJIFILM Corporation
    公开号:EP2141206B1
    公开(公告)日:2014-12-03
  • Photosensitive Compositions, Curable Compositions, Novel Compounds, Photopolymerizable Compositions, Color Filters, and Planographic Printing Plate Precursors
    申请人:Tsuchimura Tomotaka
    公开号:US20090023085A1
    公开(公告)日:2009-01-22
    A photosensitive composition includes a compound represented by Formula (I) and a curable composition contains the compound of Formula (I) and a polymerizable compound. A compound is represented by a Formula (1) and a photocurable composition contains the compound of Formula (1) and a polymerizable compound. In Formula (I), R, R 1 and R 2 each independently represent a hydrogen atom or a monovalent substituent. In Formula (1), R and B each independently represent a monovalent substituent, A represents a divalent organic group, and Ar represents an aryl group.
  • NOVEL COMPOUND, POLYMERIZABLE COMPOSITION, COLOR FILTER, AND METHOD OF PRODUCING THE SAME, SOLID-STATE IMAGING DEVICE, AND PLANOGRAPHIC PRINTING PLATE PRECURSOR
    申请人:Makino Masaomi
    公开号:US20110267714A1
    公开(公告)日:2011-11-03
    Provided is a photopolymerizable composition that is highly sensitive to light having wavelengths of 365 nm and 405 nm, and is capable of forming a curable film that can suppress deterioration in physical properties of the film due to heat-aging. The photopolymerizable composition include: (A) an oxime polymerization initiator which includes a condensed ring formed by containing two or more rings selected from an aromatic ring and a heterocyclic ring, and a cyclic structure which is connected to the condensed ring, the cyclic structure containing a carbonyl group and having an oxime group directly connected to the carbonyl group; and (B) a polymerizable compound.
  • US8846277B2
    申请人:——
    公开号:US8846277B2
    公开(公告)日:2014-09-30
  • [EN] THIOTRIAZOLYL DERIVATIVES<br/>[FR] DERIVES DE THIOTRIAZOLYLE
    申请人:EPIX DELAWARE INC
    公开号:WO2007047394A2
    公开(公告)日:2007-04-26
    [EN] The invention relates to KvI.5 ion channel antagonists. Novel thiotriazolyl derivative compounds represented by Formula I, and synthesis and uses thereof for treating diseases mediated directly or indirectly by KvI.5 ion channels, are disclosed. Such conditions include numerous heart conditions including atrial fibrillation and other diseases; as well as epilepsy, anxiety, depression, age-related memory loss, migraine, obesity, Parkinson's disease or Alzheimer's disease. Methods of preparation and novel intermediates and pharmaceutical salts thereof are also provided.
    [FR] L'invention concerne des antagonistes des canaux ioniques Kv1.5. Elle concerne notamment de nouveaux dérivés de thiotriazolyle représentés par la formule (I) ainsi que la synthèse et les utilisations de ceux-ci pour traiter des maladies médiées directement ou indirectement par les canaux ioniques Kv1.5. Ces maladies incluent diverses affections cardiaques, telles que la fibrillation auriculaire et d'autres maladies, ainsi que l'épilepsie, l'anxiété, la dépression, la perte de mémoire liée à l'âge, la migraine, l'obésité, la maladie de Parkinson ou la maladie d'Alzheimer. L'invention concerne en outre des procédés de préparation ainsi que de nouveaux produits intermédiaires et des sels pharmaceutiques correspondants.
查看更多